Piper Sandler on Ardelyx, Inc (ARDX): 'Remain Buyers for the Ibsrela Growth Story'
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel reiterated an Overweight rating and $16.00 price target on Ardelyx, Inc (NASDAQ: ARDX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
